Victory Capital Management
INBX icon

Victory Capital Management’s Inhibrx INBX Stock Holding History

Victory Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45M Buy
36,443
+25,519
+234% +$2.56M ﹤0.01% 1477
2026
Q1 		$734K Sell
10,924
-1,039
-9% -$77.1K ﹤0.01% 1944
2025
Q4 		$945K Buy
+11,963
New +$815K ﹤0.01% 1863

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management's INBX Position: Q2 2026 in Review

Victory Capital Management increased its Inhibrx (INBX) stake by 234% in Q2 2026, buying an estimated $2.56M and bringing the position to 36,443 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Victory Capital Management first reported a position in INBX in Q4 2025 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Victory Capital Management held 36,443 shares of Inhibrx worth $3.45M as of Q2 2026.
  • Victory Capital Management bought 25,519 Inhibrx shares in Q2 2026, an estimated $2.56M.
  • Inhibrx made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1477 holding.
  • Victory Capital Management first reported a position in Inhibrx in Q4 2025 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.